Chair of DSI-Mandela Nanomedicine
Dr Steven Maluta Mufamadi
Faculty: Health Sciences
Biosketch of Chair Dr Steven Mufamadi
Dr. Maluta Steven Mufamadi is a renowned scientist, entrepreneur, and advocate for the advancement of sustainable nanotechnology. He holds a PhD in Pharmaceutics from the University of the Witwatersrand and is the founder and managing director of Nabio Consulting (Pty) Ltd., a company that provides strategic consultancy services in nanotechnology and healthcare innovation.
Dr. Mufamadi's expertise spans the fields of nanomedicine, pharmaceutical sciences, and biotechnology. He serves as an external expert evaluator at The South African Health Products Regulatory Authority (SAHPRA). He has made significant contributions to the development of novel drug delivery systems, nanosensors, and biomaterials for the diagnosis, treatment, and prevention of various diseases. His research is characterized by its focus on sustainable nanotechnology, employing green synthesis methods to minimize environmental impact.
Beyond his scientific endeavors, Dr. Mufamadi is a passionate advocate for promoting STEM education and fostering innovation in Africa. He is the founder of the International Nano4Youth and Nanomedicine Ambassadors program (NAP), which aims to inspire young people to pursue careers in science and technology. He also holds leadership positions in various organizations, including the African Science, Technology and Policy Institute (ASTEPI) and the International Network for Sustainable Nanotechnology (N4SNano).
Dr. Mufamadi's contributions have been recognized through numerous accolades, including the NSTF South32 Awards Finalist in 2019/2020. He is widely regarded as a thought leader in nanotechnology and a pioneer in sustainable innovation, making significant strides in advancing healthcare and environmental protection. His dedication to education and mentorship leaves a lasting impact on the next generation of scientists and innovators.
Relevance of research
The Nelson Mandela University Nanomedicine Platform's research aligns with several UN Sustainable Development Goals (SDGs) and South African developmental goals.
• Contributes to reducing the burden of non-communicable diseases.
• Improves access to quality healthcare.
• Promotes innovation and technology development.
• Advances healthcare and improves quality of life.
Current research interests
The Nelson Mandela University Nanomedicine Platform is developing novel nanotechnology-based medical therapies to address various healthcare challenges,
• Including diabetic foot ulcers (chronic wound healing),
• Cancer (e.g., triple-negative breast cancer, colon cancer etc),
• Environmental health pathogens (e.g., tuberculosis,)
• Blood transfusions (trauma, surgery, or other medical procedures)
Find out more...